The New Magstim Rapid
Welcony Introduces the Next Evolution in TMS Research - The New Magstim Rapid TMS System
Innovation never stands still at Magstim, and neither should your research or TMS therapy. That's why Magstim, a Welcony brand is proud to announce the release of the New Magstim Rapid TMS System.
The new Magstim Rapid represents a significant evolution of one of neuroscience’s most trusted TMS systems. Designed for enhanced performance, greater ease of use, and seamless integration with other technologies, this next-generation device unlocks new potential in transcranial magnetic stimulation (TMS) research.
Click here to view promo video.
The New Magstim Rapid is FDA cleared for stimulation of peripheral nerves in pain relief, medical professionals can unlock new potentials for the treatment of pain in patients*.
The enhanced Rapid TMS System introduces a host of new features tailored to the needs of researchers and clinicians. Its modern 15” touchscreen and streamlined, user-friendly software deliver an intuitive experience. Built on a Windows-based platform, it offers improved compatibility/external integrations. Whether you're exploring brain function, investigating pain mechanisms, or working with EMG, EEG, or TMS-evoked potentials, the new Rapid equips you with the precision and flexibility to advance your research and discover new insights.
Key Features of the New Rapid System:
- FDA cleared for stimulation of peripheral nerves in pain relief
- NEW 15” touchscreen for a modern, responsive interface
- Windows-based platform for enhanced external integration
- Improved MEP functionality for superior signal quality
- Streamlined patient data management tools
- Multiple configurations: Standard Rapid (50Hz), Super Rapid (100Hz), and Super Rapid Plus1 (100Hz)
- Optional extras: TMS cart, treatment chair, and a variety of standard and sham coils
- Stimulator pulse configurations include: Biphasic, repetitive, standard and burst stimulation
Magstim’s Rapid series has long been a go-to choice for researchers across the globe, cited in thousands of peer-reviewed studies**. Now, with enhanced configurability, performance, and connectivity, this latest system ensures you stay at the forefront of neuromodulation technology.
Unlock new possibilities with the New Magstim Rapid TMS system — your gateway to groundbreaking discoveries.
“The New Magstim Rapid is grounded in research and driven by quality. The Magstim Rapid is one of the most requested and used systems in the world of TMS. Walk into almost any neuroscience research institution or hospital or clinic using neuromodulation and you will likely see a Magstim Rapid. The team worked with users worldwide to build enhancements that will carry the Rapid into the next generation.” – Ronnie Stolec-Campo, CEO, Welcony.
To book a free virtual demonstration, please contact us.
*FDA Cleared for the stimulation of peripheral nerves for relief of chronic intractable, post-traumatic, and post-surgical pain for patients 18 and older.